Study on Solid Forms of Upadacitinib: Crystal Structures, Physicochemical Properties, and Phase Transformation
Crystal Growth & Design · 16.11.2026
DOI: 10.1021/acs.cgd.6c00553 ↗Kurz gefasst
Fachartikel in der Zeitschrift Crystal Growth & Design, online erschienen am 16.11.2026. Verfasst von Bozhang Li und 12 weiteren Autor:innen. Die Arbeit nennt 50 Literaturangaben. Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, Taishan Scholar Foundation of Shandong Province, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Upadacitinib (UPA) is an important selective Janus kinase 1 (JAK1) inhibitor used for the treatment of various chronic inflammatory diseases. However, the detailed crystal structures, systematic physicochemical studies, and phase transformation relationship of UPA solid forms were not reported. In this work, one hemihydrate, two anhydrous polymorphs, and an amorphous form of UPA were successfully prepared. The crystal structures of Forms I, II, and III were determined for the first time using single-crystal X-ray diffraction. Form I was identified as an isolated-site hydrate in which water molecules form strong hydrogen bonds with UPA molecules, playing a crucial role in structural stability. Form II and Form III are packing polymorphs with similar molecular conformations but distinct lattice arrangements. Furthermore, the key physicochemical properties of these UPA forms were evaluated, including thermal behavior, hygroscopicity, and solubility. The higher melting point and fusion enthalpy of Form II indicate a monotropic relationship between Forms II and III, with Form II being the thermodynamically stable polymorph and Form III being the metastable polymorph. Competitive slurry experiments further showed that Form II is favored in anhydrous acetonitrile, whereas Form I is favored under water-containing conditions. These findings highlight the critical role of hydration in UPA solid form stability and provide a rational basis for selecting the optimal form for pharmaceutical development.
Förderung
- Basic and Applied Basic Research Foundation of Guangdong Province
- Taishan Scholar Foundation of Shandong Province
- Natural Science Foundation of Shandong Province
- Higher Education Discipline Innovation Project
- National Natural Science Foundation of China (NSFC)
- Postdoctoral Innovation Program of Shandong Province
Zitieren
APA
Li, B., Li, H., Wang, T., Wang, L., Qu, Y., Han, P., Zhang, X., Qin, C., Fan, W., Sun, K., Li, J., Tao, X., & Song, W. (2026). Study on Solid Forms of Upadacitinib: Crystal Structures, Physicochemical Properties, and Phase Transformation. Crystal Growth & Design. https://doi.org/10.1021/acs.cgd.6c00553
Vancouver
Li B, Li H, Wang T, Wang L, Qu Y, Han P, et al. Study on Solid Forms of Upadacitinib: Crystal Structures, Physicochemical Properties, and Phase Transformation. Crystal Growth & Design. 2026. doi:10.1021/acs.cgd.6c00553
BibTeX
@article{Li2026,
author = {Li, Bozhang and Li, Huimin and Wang, Tan and Wang, Lei and Qu, Yaqian and Han, Peizhuo and Zhang, Xu and Qin, Chunkui and Fan, Wulei and Sun, Kangning and Li, Jiajun and Tao, Xutang and Song, Weiguo},
title = {Study on Solid Forms of Upadacitinib: Crystal Structures, Physicochemical Properties, and Phase Transformation},
journal = {Crystal Growth & Design},
year = {2026},
doi = {10.1021/acs.cgd.6c00553}
}
EUVIMED